SITE-DIRECTED NANOTHERAPEUTICS TO ABROGATE RRMS AND PROMOTE REMYELINATION REPAIR

$397,800FY2010Department of the ArmyDOD

University Of Miami, Coral Gables FL

Investigators

View source on USAspending →